Vital Farms Swings to a $31M Loss, Breaches Covenant, and Secures $185M in New Financing
VITL sits 55% above its 52-week low of $7.95.
Summary
Vital Farms posted a $31.1M Q2 loss, breached a debt covenant, and replaced its credit facility with $185M in new, higher-cost debt. Margins collapsed amid an egg glut, and the company is exiting butter and halting a major facility build.
Key Events · Earnings and Guidance · VITL
-
Q2 Loss of $31.1M
Net loss of $31.1M vs. a $16.6M profit a year ago, driven by egg oversupply, higher input costs, and a $7.8M butter inventory impairment. Gross margin collapsed to 7% from 39%.
-
Covenant Default & New Financing
Breached fixed charge coverage ratio under JPMorgan Credit Facility; obtained waiver and replaced it with a $125M Silver Point term loan (SOFR+7.50%) and a $60M JPMorgan ABL revolver, both closed August 4, 2026.
-
Butter Business Exit
Strategic decision to wind down butter products; recognized $7.8M inventory obsolescence charge in Q2, with additional costs expected through fiscal 2026.
-
Supply Control & Capex Cuts
Implementing voluntary farmer production cuts and halting construction of Vital Crossroads egg facility by end of 2026 to address oversupply; reduced workforce by ~12% of remote staff.
Analysis · VITL · Manufacturing
A dramatic reversal from profit to a $31.1 million net loss in Q2 2026 underscores the severe impact of an industry-wide egg oversupply that crushed margins. Gross margin collapsed from 39% to just 7%, and a $7.8 million charge was taken to exit the butter business. The company also disclosed a debt covenant breach, forcing a waiver and replacement of its credit facility with a new $125 million term loan and a $60 million asset-backed revolver — both carrying significantly higher interest rates. The stock buyback program was terminated. These results and the financing overhaul signal severe operational and financial stress, fundamentally altering the investment thesis.
At the time of this filing, VITL was trading at $12.30 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $524.5M. The 52-week trading range was $7.95 to $53.13. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.